Type I interferons (IFN␣/␤) are an important part of innate immunity to viral infections because they induce an antiviral response and limit viral replication until the adaptive response clears the infection. Since the nonstructural proteins of several paramyxoviruses inhibit the IFN␣/␤ response, we chose to explore the role of the C protein of measles virus (MV) in such inhibition. Previous studies have suggested that the MV C protein may serve as a virulence factor, but its role in the pathogenesis of MV remains undefined. In the present study, a recombinant MV strain that does not express the C protein (MV CϪ) and its parental strain (Ed Tag) were used. Growth of MV CϪ was restricted in human peripheral blood mononuclear cells and HeLa cells, but in the presence of neutralizing antibodies to IFN␣/␤, MV CϪ produced titers that were equivalent to those of Ed Tag. In addition, expression of the MV C protein from plasmid DNA inhibited the production of an IFN␣/␤ responsive reporter gene and, to a lesser extent, inhibited an IFN␥ responsive reporter gene. The ability of the MV C protein to suppress the IFN␣/␤ response was confirmed using a biologic assay. After IFN␤ stimulation, HeLa cells infected with Ed Tag produced five-fold less IFN␣/␤ than cells infected with MV CϪ. While the mechanism of inhibition remains unclear, these data suggest that the MV C protein plays an important role in the pathogenesis of MV by inhibiting IFN␣/␤ signaling.
Introduction
Measles virus (MV) is a member of the Morbillivirus genus within the subfamily Paramyxovirinae of the family Paramyxoviridae. Measles infection is manifest as fever, cough, coryza, conjunctivitis, and a characteristic maculopapular rash. Once a common childhood illness, measles is now successfully controlled in many areas by vaccination, though sporadic outbreaks still occur. In developing countries where vaccination coverage is low, and malnutrition, crowding, and other infectious diseases are prevalent, measles is responsible for approximately 770,000 deaths annually, making it the leading cause of death among children by a vaccine-preventable illness (WHO, 2002) . Immunosuppression resulting from measles infection can last up to 3 months, leading to secondary infections that are the primary cause of mortality (Griffin, 2001) .
Viruses in the subfamily Paramyxovirinae express one or two nonstructural proteins, C and/or V, from the phosphoprotein (P) gene. In addition to the P protein, the P genes of the Respiroviruses, Morbilliviruses, and Henipaviruses express one or more C proteins from overlapping reading frames and V is expressed from an edited mRNA. The P genes of the Rubulaviruses express P and V (Griffin, 2001; Lamb and Kolakofsky, 2001) . The single C protein of MV is 186 amino acids in size and is encoded by an open reading frame that begins 22 nucleotides downstream of the P gene start codon (Bellini et al., 1985) .
Several studies have shown that the nonstructural proteins of the paramyxoviruses inhibit the type I interferon (IFN␣/␤) response (Didcock et al., 1999a; Garcin et al., 1999; Gao et al., 2001; Gotoh et al., 2001 Gotoh et al., , 2002 Parisien et al., 2001; Young et al., 2001) . The type I IFNs, which consist primarily of IFN␣ and IFN␤, are important components of the innate immune response. These potent inflam-matory cytokines are produced by virally infected cells and serve as an early response to inhibit viral replication by preventing the infection of neighboring cells and initiating the adaptive immune response (Stark et al., 1998; Goodbourn et al., 2000; Sen and Biron, 2001 ). IFN signaling is triggered by binding of IFN␣/␤ to the ubiquitous IFN␣/␤ receptor (IFNR), resulting in upregulation of IFN␣/␤ responsive genes, including double-stranded RNA-dependent protein kinase (PKR), 2Ј-5Ј-oligoadenylate synthetase, major histocompatibility class I (MHC I), and the Mx family of proteins. In addition to generating an antiviral state in the cell, IFN␣/␤ are known to have potent immunomodulatory effects such as enhancement of dendritic cell maturation, activation macrophages, and extension of T cell life spans (Stark et al., 1998; Goodbourn et al., 2000; Sen and Biron, 2001) .
Previous reports have shown that IFN␣/␤ induction by MV was dependant on passage history of the virus and the cell type tested (Volckaert-Vervliet and Billiau, 1977; Volckaert-Vervliet et al., 1978; Naniche et al., 2000) , and the MV V protein has been shown to inhibit IFN␣/␤ signaling (Palosaari et al., 2003; Takeuchi et al., 2003) . Since the MV C protein has been shown to be a virulence factor (Valsamakis et al., 1998; Escoffier et al., 1999; Mrkic et al., 2000; Patterson et al., 2000) and to bind to the IFNR along with the MV V protein (Yokota et al., 2003) , we explored the role that this protein plays in the inhibition of IFN␣/␤ responses by MV. Here we report that the MV C protein inhibited the production of IFN␣/␤ by human cells and inhibited IFN␣/␤ signaling.
Results

The replication of MV CϪ is restricted in cells of human origin
The two viruses used in this study were derived from an infectious clone of measles virus. The infectious clone of Ed Tag is based on the prototype Edmonston sequence and contains three unique nucleotide substitutions in noncoding regions that serve as genetic markers. MV CϪ was derived from the infectious clone of Ed Tag and contains additional nucleotide substitutions to prevent expression of the C protein (Radecke and Billeter, 1996; Schneider et al., 1997) . To evaluate the relative replicative abilities of MV CϪ and Ed Tag, various cell types were infected at a multiplicity of infection (m.o.i.) of 0.1 and viral titers were measured after 5 days of incubation. Vero cells, which cannot produce IFN␣/␤ (Mosca and Pitha, 1986) , are derived from African green monkey kidney fibroblasts and are commonly used for virus propagation. CV-1 cells are an IFN␣/␤ competent (Thacore et al., 1990 ) simian fibroblast cell line, and B95-8a cells are an Epstein-Barr virus transformed, marmoset B cell line that is the preferred cell line for isolation of MV from clinical specimens (Kobune et al., 1990) . Ed Tag and MV CϪ produced equivalent titers in the nonhuman primate cell lines Vero, B95a, and CV-1 (Fig. 1) .
In HeLa cells and primary PBMC, both of which are IFN␣/␤ competent and of human origin, MV CϪ produced titers that were approximately 2-3 logs lower than the titers produced by Ed Tag (Fig. 1) , and similar results were obtained from primary human lung microvascular endothelial cells (HLMEC) (data not shown). The titers obtained after infection of human PBMC with MV CϪ and Ed Tag were similar to those previously reported by Escoffier et al. (1999) . Taken together, these results show that replication of MV CϪ was restricted in cells of human origin that are IFN␣/␤ competent; however the restriction was not observed in IFN␣/␤ competent cells of simian origin.
Growth of MV CϪ in human cells can be rescued by addition of antibodies to IFN␣/␤
To determine if IFN␣/␤ were responsible for the restricted growth of MV CϪ in the cells of human origin, peripheral blood mononuclear cells (PBMC) and HeLa cells were infected at an m.o.i. of 0.1, with Ed Tag or MV CϪ in the presence of normal rabbit serum or neutralizing antibodies to IFN␣/␤ and incubated for 48 h. In the presence of anti-IFN␣/␤ antibodies, titers of MV CϪ were equivalent to those of Ed Tag (Fig. 2) . The growth of MV CϪ was restricted in the cultures treated with normal rabbit serum, while the titers of Ed Tag were not affected (Fig. 2) . The anti-IFN␣/␤ antibodies were tested over a range of concentrations and the results in Fig. 2 were obtained by using the highest concentration of antibodies that rescued the growth of MV CϪ. These results suggested that the reduced growth of MV CϪ in human cell types was due to the antiviral effects of the type I IFNs.
MV reduces IFN␣/␤ production following IFN stimulation of infected cells
Since neutralizing IFN␣/␤ rescued the growth of MV CϪ in human cells, we tested the ability of HeLa cells that were infected with Ed Tag or MV CϪ to produce IFN␣/␤ in response to recombinant IFN␤ (rIFN␤) stimulation. The 4-h stimulation with rIFN␤ was necessary because this assay was not sufficiently sensitive to detect IFN␣/␤ production by unstimulated, MV-infected HeLa cells. Attempts were made to measure IFN␤ production in infected cells by using flow cytometry or EIA, but these experiments were unsuccessful. Supernatants from the infected HeLa cells were transferred in two-fold serial dilutions to Vero cells where the presence of IFN␣/␤ was measured as protection from encephalomyocarditis (EMC) virus-mediated lysis.
Ed Tag blocked the production of IFN␣/␤ by HeLa cells when stimulated with rIFN␤, while HeLa cells infected with MV CϪ produced IFN␣/␤ after rIFN␤ stimulation. Supernatants from HeLa cells infected with MV CϪ, or treated with a mock-infected Vero cell lysate, contained significantly more IFN␣/␤ than supernatants from HeLa cells infected with Ed Tag (Fig. 3 ). HeLa cells treated with an uninfected Vero cell lysate produced IFN␣/␤ in response to rIFN␤ stimulation, indicating that differences in the IFN␣/␤ response were a result of viral infection and not a response to a component of the inoculum. In addition, supernatant medium from HeLa cells infected with MV CϪ that was incubated with antibodies to IFN␣/␤ lost the ability to prevent the EMC-mediated lysis. Vero cells were inoculated with HeLa cell supernatants and incubated for 5 days to demonstrate that they did not contain detectable quantities of MV as measured by plaque formation. These results suggest that not only can the growth of MV CϪ be inhibited by IFN␣/␤, but MV CϪ has lost the ability to inhibit the production of IFN␣/␤ in stimulated cells.
Viral stocks containing high levels of defective interfering particles do not inhibit the IFN␣/␤ response
Our data indicating that MV C protein inhibits the IFN␣/␤ response were obtained by using viral stocks that were prepared in Vero cells. Previous work by Naniche et al. (2000) showed that strains of MV that had been isolated on PBMC or B95a cells induced 10 times more IFN␣/␤ after they were passaged in Vero cells, suggesting that host cell passage had selected for viruses that differed in their ability to induce IFN␣/␤. In our experiments Ed Tag and MV CϪ were plaque purified before stocks were prepared by low m.o.i. of Vero cells. Since passage of MV in Vero cells at high m.o.i. results in the accumulation of defective interfering particles (DIs) (Whistler et al., 1996) , interference assays were used to confirm the absence of DI activity in the viral stocks used in our experiments.
To test the effect of DIs on IFN␣/␤ induction, a DI containing stock of Ed Tag (Ed Tag-DI) was produced by serial undiluted passage in Vero cells. This stock had an interference activity that reduced titers of standard virus by 2 logs. Supernatants from IFN␤-stimulated HeLa cells infected with Ed Tag-DI contained significantly more IFN␣/␤ than supernatants from Ed Tag infected Vero cells, or mockinfected Vero cells. The inhibition of IFN␣/␤ induction that was observed after infection with plaque-purified stocks of Ed Tag was not observed when the stock contained detectable interference activity (Fig. 3) . These data suggest that the inability of Vero passaged viruses to inhibit IFN␣/␤ is dependent on the presence of DIs and is not a result of host cell selection of viruses. 
The MV C protein blocks induction of IFN␣/␤ and IFN␥ responsive reporter genes
To test the effect of the MV C protein on induction of an IFN␣/␤ responsive gene, the MV C protein was expressed in Vero cells that were transfected with plasmids encoding the firefly luciferase gene under the control of an ISRE. Expression of the MV C protein inhibited IFN␣/␤-induced luciferase production by more than 90% (Fig. 4A) relative to cells transfected with the plasmid vector alone or a plasmid expressing the irrelevant viral protein, the glycoprotein of Nipah virus. In addition, cells that were not stimulated with rIFN␤ produced much lower levels of luciferase, indicating that the ISRE-dependent gene expression was restricted to stimulated cells. These results suggest that expression of the MV C protein, in the absence of other MV proteins, can inhibit the induction of IFN␣/␤ responsive genes.
Since the type I and type II IFN signaling pathways share some components, the effect of the MV C protein on IFN␥ signaling was also tested using a similar luciferase reporter plasmid containing an IFN␥ activating sequence (GAS) that is IFN␥ responsive. Expression of the MV C protein inhibited luciferase production by 50% from this plasmid compared with production by cells that were transfected with the control vector plasmid alone. These findings were not due to a global downregulation of transcription or translation since Western blots showed no differences in the amount of cellular actin present in infected PBMC. The inhibition of both types of IFN suggested the possible involvement of STAT1, since this molecule is critical in both signaling pathways.
STAT1 is present at higher levels in MV CϪ infected cells than in those infected with Ed Tag
Since other paramyxoviruses target STAT1 for degradation, Western blots were performed to measure STAT1 levels in PBMC infected with Ed Tag or MV CϪ. The amounts of STAT1 present in rIFN␤-stimulated and unstimulated mock-infected PBMC were compared with STAT1 levels in unstimulated cells infected with either Ed Tag or MV CϪ. STAT1 levels were measured by luminescence and normalized to cellular actin levels. Relative to levels in the unstimulated, mock-infected PBMC, MV CϪ infected PBMC expressed higher levels of STAT1 (48.5%) than Ed Tag infected PBMC (14.3%) (Fig. 5) . Cellular actin levels were equivalent in all of the cultures, and flow cytometric analysis to detect the MV N protein indicated that approximately 70% of the cells were infected with either Ed Tag or MV CϪ (data not shown). The activation state of STAT1 in these cells is unknown; however, STAT1 is a critical protein in both type I and type II IFN signaling pathways, and these data suggest that in human PBMC, the absence of the MV C protein correlates with higher levels of STAT1.
Since the increased STAT1 levels found in MV CϪ infected PBMC could be due to either STAT1 degradation by the MV C protein or an increase in STAT1 levels due to IFN␣/␤ production and signaling, Western blots were performed on Ed Tag and MV CϪ infected Vero cells. Since Vero cells are not able to produce IFN␣/␤, STAT1 levels will not change in response to IFN␣/␤ produced by neighboring cells. STAT1 was present at similar levels in both Ed Tag infected and Vero lysate treated cells, indicating that the measles infection does not result in the degradation of STAT1. When normalized to cellular actin levels, STAT1 was present at slightly higher levels in MV CϪ infected cells than in the cells infected with Ed Tag (Fig. 5C ).
Discussion
This article provides direct evidence that the MV C protein inhibits IFN signaling and the ability to respond to IFN stimulation. This is also the first report of IFN␣/␤ inhibition by the C protein of a Morbillivirus. The results presented here are consistent with those of previous studies suggesting that MV C is a virulence factor. Relative to Ed Fig. 4 . The MV C protein inhibits expression of interferon-responsive reporter genes. Vero cells were transfected with plasmids containing the luciferase reporter gene under the control of an IFN␣/␤ responsive promoter (A) or an IFN␥ responsive promoter (B), the plasmid constitutively expressing renilla luciferase, and either the plasmid vector control, plasmid expressing MV C, or plasmid expressing Nipah G. Twenty-four hours later, the cells were stimulated with 100 U rIFN␤. Expression levels of the firefly luciferase reporter gene were normalized to the expression levels of the constitutively expressed renilla luciferase reporter gene to control for transfection efficiency. Results are expressed as a percentage of firefly luciferase expression relative to the positive control (vector alone).
Tag, MV CϪ showed reduced growth in human thymus tissue that was transplanted into SCID mice as well as reduced titers and mortality in YAC-CD46 transgenic mice and IFNR Ϫ/Ϫ , CD46 transgenic mice (Valsamakis et al., 1998; Mrkic et al., 2000; Patterson et al., 2000) . The C protein is not required for viral growth in Vero cells (Radecke and Billeter, 1996; Schneider et al., 1997) . Interestingly, when MV isolates from the same clinical specimen but isolated independently in B95a and Vero cells were sequenced, the Vero cell-passaged virus had a mutation in P gene that produced a premature stop codon in the reading frame for the C protein (Takeuchi et al., 2000) .
Previous studies had shown that MV CϪ produced titers that were nearly 3 logs lower than those of Ed Tag in human PBMC and these reduced titers correlated with reduced levels of MV mRNA and viral proteins (Escoffier et al., 1999) . Here, we expand on this observation to show that growth of MV CϪ was restricted in other IFN␣/␤ competent cells of human origin and that growth could be rescued by addition of antibodies to IFN␣/␤.
Our results are consistent with those in numerous other reports, some dating back more than 40 years, which showed paramyxoviruses are able to inhibit the type I IFNs (Valle and Cantell, 1965; Maeno et al., 1966) . In particular, the replication of various strains of MV was inversely correlated with IFN␣/␤ production Billiau, 1977, Volckaert-Vervliet et al., 1978) , and 2Ј-5Ј-oligoadenylate synthetase was poorly induced in measlesinfected neurons (Fujii et al., 1990) . More recent reports showed that wild-type MV suppressed IFN␣ signaling and impaired Jak1 phosphorylation (Yokota et al., 2003) and that strains of MV that had only been passaged in B95-8a cells or PBMC did not induce IFN␣/␤ induction in human PBMC (Naniche et al., 2000) , but induced IFN␣/␤ following passage in Vero cells. DIs can accumulate in as few as two to three passages in Vero cells (Calain and Roux, 1988; Whistler et al., 1996) , and our results showed that stocks containing high levels of interference activity consistently lost the ability to inhibit IFN␣/␤ induction. In this article, plaque-purified viral stocks with no measurable interference activity were used to test the relative abilities of the Ed Tag and MV CϪ viruses to inhibit the IFN␣/␤ response.
The results presented here contribute to a growing body of evidence indicating that the nonstructural proteins encoded by the P genes of paramyxoviruses function as virulence factors by inhibiting the production of and cellular response to the type I IFNs. The C proteins of Sendai virus (SeV) have many functions, one of which is to inhibit type I IFN production and responsiveness (Garcin et al., 1999; Gotoh et al., 1999) . In addition, the C proteins of SeV prevented accumulation of STAT1 and suppressed the induction of STAT2, IRF-9, and PKR (Gotoh et al., 1999) . The SeV C proteins altered the phosphorylation and dephosphorylation of STAT1 and partially inhibited phosphorylation of Tyk2 Saito et al., 2002) . Expression SeV C proteins inhibited expression of IFN␣/␤ responsive reporter genes (Garcin et al., 2000) , though conflicting data exist as to which of the SeV C proteins was responsible for the inhibition (Garcin et al., 2001 (Garcin et al., , 2002 Kato et al., 2001 ). In the Rubulaviruses, which do not express a C protein, the V protein inhibits the type I IFN response. The V protein of SV5 reduced STAT 1 levels and this effect was abolished by proteosome inhibitors (Didcock et al., 1999b) . SV5 V, STAT1, and STAT2, together with unidentified proteins, formed a complex that targeted STAT 1 for degradation (Young et al., 2001; Parisien et al., 2002a Parisien et al., , 2002b . The V protein of mumps virus (MuV) also degraded STAT1 and binding of the MuV V protein to STAT1 led to its ubiquitation Yokosawa et al., 2002) . While SV5 and MuV promote degradation of STAT1, the V protein of human parainfluenza virus-2 inhibited type I IFN by binding STAT2 and targeting it for degradation (Young et al., 2000; Parisien et al., 2001b Parisien et al., , 2002 Andrejeva et al., 2002) . The Nipah virus V protein bound STAT1 and STAT2, forming large complexes that could not translocate into the nucleus and activate transcription (Rodriguez et al., 2002) . Measles virus also expresses a V protein that also inhibits IFN␣/␤ signaling (Palosaari et al., 2003; Takeuchi et al., 2003) . When constitutively expressed in HeLa cells, the V protein inhibited tyrosine phosphorylation of both STAT1 and STAT2 (Takeuchi et al., 2003) , but inhibition of phosphorylation was not observed when the protein was transiently expressed in cells (Palosaari et al., 2003) . The MV V protein bound STAT1, STAT2, STAT3, and IRF-9 and prevented nuclear accumulation of the STAT molecules (Palosaari et al., 2003) .
The data presented here show that the MV C protein inhibits the cellular response to IFN␣/␤ signaling. Our results agree with those of previous observations that MV infection does not result in degradation of STAT1 (Palosaari et al., 2003; Takeuchi et al., 2003) . However, the observation that IFN␣/␤ signaling was not inhibited in HeLa cells stably expressing the MV C protein (Takeuchi et al., 2003) differs from our results which were obtained in MV-infected HeLa cells and by IFN␣/␤ responsive reporter gene assays. It is important to note that our data were obtained using the MV CϪ virus, which expresses a V protein, and that the relative contributions of the MV C and V proteins to the inhibition the IFN␣/␤ responsiveness in vivo are not known. Studies to define the mechanism of MV C-mediated inhibition of IFN␣/␤ as well as to evaluate the relative IFN␣/␤ inhibition levels of C proteins from wild-type and vaccine strains of MV are in progress.
Methods and materials
Cells and viruses
Experiments were performed in the following cell types: HeLa (ATCC: CCL-2) cells cultured in F12 medium (Gibco, Grand Island, NY), Vero cells (ATCC: CCL-81) cultured in modified Eagle's medium (MEM, Gibco), B95-8a cells (Kobune et al., 1990 ) cultured in Dulbecco's modified Eagle's medium (Gibco), CV-1 cells (ATCC: CCL-70), also cultured in Dulbecco's modified Eagle's medium (Gibco), and human PBMC cultured in RPMI medium 1640 (Gibco). All medium was supplemented with 10% fetal bovine serum (FBS) (Hyclone, Logan, Utah), 100 U/l Penicillin (Gibco), and 100 U/l Streptomycin (Gibco). The MEM was also supplemented with 2 mM L-glutamine (Gibco). All PBMC were from a single donor and were isolated by centrifugation over a Ficoll-Hypaque gradient.
Plaque-purified virus stocks were prepared in Vero cells and tested for interference activity as described below. Viral titers were measured by plaque assay (Rota et al., 1994) in Vero cells. The MV CϪ virus, which does not express the C protein, and the Ed Tag virus (Radecke and Billeter, 1996; Schneider et al., 1997) were gifts from Dr. Martin Billeter. Ed Tag was rescued from an infectious clone that was based on the sequence of the prototype, Edmonston strain of MV, and MV CϪ was derived from the infectious clone for Ed Tag. MV CϪ has two mutations in the C reading frame, which are silent in the P reading frame, that eliminate the start codon and insert an extra downstream stop codon. The presence of the mutations was confirmed by sequencing and the lack of C protein expression was confirmed by using immunofluorescence with rabbit antipeptide antiserum (Bellini et al., 1985) . Virus stocks were plaque-purified three times in Vero cells. These parent stocks were then passaged at an m.o.i. of 1.0 three times to generate stocks containing defective interfering particles. The titer of stock was measured by using a standard plaque assay on Vero cells. Interference was measured as previously described (Whistler et al., 1996) . Viral stocks containing DI particles inhibited showed 1-2 logs of interference activity.
Viral replication and rescue experiments
B95-8a, CV-1, PBMC, and Vero cells were infected with Ed Tag or MV CϪ at an m.o.i. of 0.1. Cultures were incubated for 5 days and harvested as cell lysates by freezing and thawing. Viral titers were determined as described above.
Human PBMC (1 ϫ 10 6 ), purified as described above, were infected with MV at an m.o.i. of 0.1 in RPMI containing 10% FBS and 5 g/ml PHA (Sigma, St. Louis, MO), and either 8 l/ml normal rabbit serum or 4 l/ml antibody to IFN␣ (Mab413, Chemicon, Temecula, CA) and 800 neutralizing units/ml antibody to IFN␤ (Mab1431, Chemicon). Cells were incubated for 2 days before being harvested. Viral titers were determined as described above. HeLa cells in F12 medium containing 5% FBS, 100 U/l of penicillin, and 100 U/l of streptomycin were infected at an m.o.i. of 0.1 in the presence of the same antibodies described above. The procedure for harvest and measurement, was as described above. Antibodies have been shown to be neutralizing by manufacturer and also in our biological IFN␣/␤ assay (J. Shaffer, unpublished observation).
Biologic IFN␣/␤ assay
IFN␣/␤ production was measured by testing for inhibition of cell lysis by EMC virus similar to a method previously described (Yeh et al., 1982) . HeLa cells were infected with MV at an m.o.i. of 0.1, and control cells were treated with an equivalent volume of an uninfected Vero cell lysate. The infection continued for 24 h at 37°C, at which time the supernatants were removed, the cells were washed, and 100 U recombinant IFN␤ (BioSource International, Camarillo, CA) was added in 200 l F12. After 1 h at 37°C, the cells were washed twice with medium, and 200 L F12 medium containing 2% FBS was added. After 1 h at 37°C, 150 l of the supernatant was transferred to confluent Vero cells as two-fold serial dilutions in MEM containing 2% FBS. The Vero cells were then infected by adding 5000 PFU EMC to the medium. The infection continued for 24 h at 37°C, and the cells were fixed and stained with crystal violet (15% formaldehyde, 2.5% ethanol, 0.65 g crystal violet in 1 L PBS). Cells were washed with PBS and lysis was detected by the visible presence or absence of an intact cell monolayer in the well.
Measurement of expression of IFN-responsive genes
A plasmid containing the MV C gene under the control of a CMV promoter, pCMV-C, was made by using RT-PCR to amplify the P gene from RNA extracted from cells infected with the Edmonston wild-type strain. The primers 5Ј gat cga att cca ggc acg cca tgt ca 3Ј and 5Ј gat cct cga ggc tgt agc tac ttc at 3Ј were designed so that the first 12 nucleotides of the P open reading frame were not amplified. This amplicon was digested with EcoR1 and XhoI and ligated into the plasmid vector pCMV (Stratagene, Cedar Creek, TX). Expression of MV C from this plasmid was confirmed by performing immunofluorescence assays on transfected cells and MV C was detected with rabbit antipeptide antiserum (Bellini et al., 1985) . The pCMV-NipG construct was used as a control (Harcourt et al., 2000) . The pISRE and pGAS plasmids were gifts from Dr. R.E. Randall (North Haugh University of St. Andrews, Fife, Scotland). pISRE encodes the firefly luciferase gene following four tandem repeats of the interferon stimulation response element (ISRE) from the IFN inducible gene 9-27 (King and Goodbourn, 1998; Didcock et al., 1999a; Garcin et al., 1999) . pGAS contains the minimal thymidine kinase promoter and two tandem repeats of the IFN␥ activating sequence (GAS) from the IRF-1 gene (King and Goodbourn, 1998) . The pRL-TK plasmid encodes the renilla luciferase gene constitutively expressed from a thymidine kinase promoter and is used as a transfection control.
Vero cells in 24-well tissue culture plates were transfected using FuGene (Roche, Indianapolis, IN) in MEM with 2% FBS according to the manufacturer's protocol and 0.9 g of the plasmids pISRE or pGAS were cotransfected with 0.05 g pRL-TK (Promega, Madison WI) and 1 g pCMV-C, pCMV-NipG, or pCMV. Cells were allowed to recover from transfection for 24 -28 h and were stimulated with 100 U recombinant IFN␤ (BioSource International) for 6 h, and cell lysates were harvested for detection of luciferase. Luciferase production was measured using the Dual Reporter Luciferase System (Promega) according to the manufacturer's protocol. Chemiluminescence was recorded on a closed circuit digital camera (Alpha Innotech, San Leandro, CA) and quantified by densitometry. The ratio of firefly luciferase expressed to the amount of renilla luciferase expressed was calculated to control for transfection efficiency. Those ratios were then expressed as (experimental/vector control) ϫ 100%.
Western blots
The medium was removed 24 h postinfection from infected, mock-infected, or IFN␤ (500 U) stimulated human PBMC (1 ϫ 10 6 cells) or Vero cells and 500 l RIPA (1% sodium deoxycholate, 1% Triton X-100, 0.2% SDS, 150 mM NaCI, 50 mM Tris-HCl at pH 7.5) buffer was added. Cell lysates were subjected to electrophoresis through 4 -20% SDS-polyacrylamide gels (Bio-Rad, Hercules, CA), and then transferred to microporous polyvinylidene difluoride (PVDF) membranes (Roche). The membranes were incubated in a 5% non-fat milk, 0.01% Tween, 0.01 M PBS solution before adding primary antibodies. The primary antibodies, anti-STAT1 clone C-136 (Santa Cruz Biotechnology, Santa Cruz, CA) and antiactin (Chemicon) were used at concentrations of 1:100 and a secondary anti-mouse IgG1-horseradish peroxidase antibody (Zymed, San Francisco, CA) was used at a concentration of 1:1000. The chemiluminescent substrate (KPL, Gaithersburg, MD) was used according to the manufacturer's protocol and a radiograph was generated by exposing the filter to X-ray film.
